Adverum Biotechnologies Stock (NASDAQ: ADVM)

Adverum Biotechnologies

ADVERUM BIOTECHNOLOGIES INC

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies Inc

Press Releases

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM

Earnings

Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones

News

Legal

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ADVM

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals

Adagene Inc. - ADS, each representing 1.25 ordinary shares

Adagene

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics

Alterity Therapeutics Limited - American Depositary Shares

Alterity Therapeutics

Biomea Fusion

Cibus

Caribou Biosciences

Citius Oncology

IGM Biosciences

I-MAB

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

IO Biotech

Invivyd

Jasper Therapeutics, Inc. - Class A Common Stock

Jasper Therapeutics

MAIA Biotechnology

Seres Therapeutics

MediciNova

Pyxis Oncology

Serina Therapeutics

Skye Bioscience

Unicycive Therapeutics, Inc. - Common Stock

Unicycive Therapeutics

Vor Biopharma

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics

Whitehawk Therapeutics, Inc. - Common Stock

Comments

Adverum Biotechnologies

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell